GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Enterprise Value

Accustem Sciences (Accustem Sciences) Enterprise Value : $4.44 Mil (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Accustem Sciences's Enterprise Value is $4.44 Mil. Accustem Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.05 Mil. Therefore, Accustem Sciences's EV-to-EBIT ratio for today is -2.16.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Accustem Sciences's Enterprise Value is $4.44 Mil. Accustem Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.05 Mil. Therefore, Accustem Sciences's EV-to-EBITDA ratio for today is -2.17.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Accustem Sciences's Enterprise Value is $4.44 Mil. Accustem Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Accustem Sciences's EV-to-Revenue ratio for today is .


Accustem Sciences Enterprise Value Historical Data

The historical data trend for Accustem Sciences's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Enterprise Value Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
Enterprise Value
14.69 7.13

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial 14.69 11.13 16.18 10.07 7.13

Competitive Comparison of Accustem Sciences's Enterprise Value

For the Biotechnology subindustry, Accustem Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accustem Sciences's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Accustem Sciences's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Accustem Sciences's Enterprise Value falls into.



Accustem Sciences Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Accustem Sciences's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Accustem Sciences's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accustem Sciences  (OTCPK:ACUT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Accustem Sciences's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.437/-2.051
=-2.16

Accustem Sciences's current Enterprise Value is $4.44 Mil.
Accustem Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.05 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Accustem Sciences's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4.437/-2.047
=-2.17

Accustem Sciences's current Enterprise Value is $4.44 Mil.
Accustem Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.05 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Accustem Sciences's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.437/0
=

Accustem Sciences's current Enterprise Value is $4.44 Mil.
Accustem Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accustem Sciences Enterprise Value Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Accustem Sciences (Accustem Sciences) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.